Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$941.7M
+15.7% from 2023
Prescriptions
108K
$8,730.12 per claim
Patients
22K
9,749 prescribers
Total spending, 2024
$941.7M
$43,063.87 per patient
Medicare prescription drug plans paid $941.7M for Venclexta in 2024, for 107,863 prescriptions and refills to 21,866 patients (up 15.7% from 2023). The average cost per claim was $8,730.12.
California had the highest Medicare cost for Venclexta in 2024: $83.3M for 9,552 claims, followed by New York ($71.2M).
Josie Montegaard, nurse practitioner in Boston, MA, had the highest Medicare cost for Venclexta in 2024: 207 claims costing $3.1M.
Venclexta is made by AbbVie Inc. (ABBV), listed in the Medicare spending data as Abbvie US LLC.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Josie Montegaard Boston, MA | Nurse Practitioner | 207 | 30 | $3.1M |
| Joshua F Zeidner Chapel Hill, NC | Hematology-Oncology | 261 | 73 | $2.1M |
| Mounzer E Agha |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 8,407 | 83,501 | 17,537 | $757.5M |
| 2023 | 8,944 | 89,227 | 18,750 | $813.9M |
| 2024 | 9,749 | 107,863 | 21,866 | $941.7M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Hematology |
| 188 |
| 28 |
| $1.9M |
| Joshua L Blocher Phoenix, AZ | Physician Assistant | 150 | 25 | $1.8M |
| Christina Baldwin New York, NY | Nurse Practitioner | 156 | 17 | $1.8M |
| Leslie A Rudolph New York, NY | Physician Assistant | 139 | 25 | $1.7M |
| Muhammad Usman Detroit, MI | Medical Oncology | 206 | 35 | $1.7M |
| Michael Y Choi San Diego, CA | Hematology-Oncology | 116 | 17 | $1.6M |
| Amy Behnken Rochester, MN | Nurse Practitioner | 108 | 15 | $1.5M |
| Teresa Fogaren Boston, MA | Nurse Practitioner | 98 | 11 | $1.5M |
| Kathleen M Leonard New York, NY | Nurse Practitioner | 167 | 19 | $1.5M |
| Lindsey Hendrickson Charleston, SC | Nurse Practitioner | 112 | 16 | $1.4M |
| Linda Ouyang New York, NY | Nurse Practitioner | 106 | 25 | $1.3M |
| Erin M Pettijohn Grand Rapids, MI | Hematology-Oncology | 114 | 24 | $1.2M |
| Mark J Fesler Saint Louis, MO | Hematology-Oncology | 159 | 32 | $1.2M |
| Timothy C Kasunic Toledo, OH | Hematology-Oncology | 100 | 16 | $1.2M |
| Mohammad Omaira Kalamazoo, MI | Medical Oncology | 134 | 24 | $1.1M |
| Sunitha Vemulapalli Canton, OH | Hematology-Oncology | 73 | 12 | $1.1M |
| Danielle M Brander Durham, NC | Hematology-Oncology | 87 | Under 11 | $1.1M |
| Timothy C Beer Lancaster, PA | Hematology-Oncology | 91 | 18 | $1.1M |
| Alice Lynn Houston, TX | Nurse Practitioner | 92 | 18 | $1.1M |
| Carter T Davis New Orleans, LA | Hematology-Oncology | 181 | 33 | $1.1M |
| Melanie H Bernstein New York, NY | Physician Assistant | 76 | Under 11 | $1.1M |
| Michael Johnson Buffalo, NY | Nurse Practitioner | 68 | 17 | $1.1M |
| Jennifer A Woyach Columbus, OH | Hematology | 74 | 12 | $1.0M |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Abbvie US LLC ABBV | 107,871 | $941.7M |